Clinical Trial Update: Evaluating the Safety and Tolerability of Antiretroviral Drug Regimens Used as Pre-Exposure Prophylaxis to Prevent HIV Infection in At-Risk Men Who Have Sex With Men and in At-Risk Women [Phase 2]

View source ↗

Summary

Phase 2 trial updating safety and tolerability of antiretroviral regimens used as pre-exposure prophylaxis (PrEP) for HIV infection in at-risk populations; comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infection | Phase 2 | Status: COMPLETED | Results posted: 2017-07-18